AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,042,174 | -73.8% | 262,828 | -67.4% | 0.00% | -76.5% |
| Q2 2023 | $7,797,569 | -45.8% | 805,534 | -38.6% | 0.02% | -52.8% |
| Q1 2023 | $14,383,323 | +624.1% | 1,312,347 | +185.4% | 0.04% | +620.0% |
| Q4 2022 | $1,986,469 | -73.1% | 459,831 | -53.3% | 0.01% | -78.3% |
| Q3 2022 | $7,398,000 | +47.5% | 983,787 | +97.1% | 0.02% | +43.8% |
| Q2 2022 | $5,017,000 | -25.3% | 499,251 | -8.0% | 0.02% | -23.8% |
| Q1 2022 | $6,717,000 | +196.6% | 542,602 | +8.5% | 0.02% | +200.0% |
| Q4 2017 | $2,265,000 | -27.8% | 500,000 | 0.0% | 0.01% | -41.7% |
| Q3 2017 | $3,135,000 | +2.3% | 500,000 | 0.0% | 0.01% | -7.7% |
| Q2 2017 | $3,065,000 | +39.2% | 500,000 | +66.7% | 0.01% | +30.0% |
| Q1 2017 | $2,202,000 | – | 300,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |